Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

412 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).
Saurat JH, Stingl G, Dubertret L, Papp K, Langley RG, Ortonne JP, Unnebrink K, Kaul M, Camez A; CHAMPION Study Investigators. Saurat JH, et al. Among authors: stingl g. Br J Dermatol. 2008 Mar;158(3):558-66. doi: 10.1111/j.1365-2133.2007.08315.x. Epub 2007 Nov 28. Br J Dermatol. 2008. PMID: 18047523 Clinical Trial.
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.
Lebwohl M, Strober B, Menter A, Gordon K, Weglowska J, Puig L, Papp K, Spelman L, Toth D, Kerdel F, Armstrong AW, Stingl G, Kimball AB, Bachelez H, Wu JJ, Crowley J, Langley RG, Blicharski T, Paul C, Lacour JP, Tyring S, Kircik L, Chimenti S, Callis Duffin K, Bagel J, Koo J, Aras G, Li J, Song W, Milmont CE, Shi Y, Erondu N, Klekotka P, Kotzin B, Nirula A. Lebwohl M, et al. Among authors: stingl g. N Engl J Med. 2015 Oct;373(14):1318-28. doi: 10.1056/NEJMoa1503824. N Engl J Med. 2015. PMID: 26422722 Free article. Clinical Trial.
Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor.
Skvara H, Kalthoff F, Meingassner JG, Wolff-Winiski B, Aschauer H, Kelleher JF, Wu X, Pan S, Mickel L, Schuster C, Stary G, Jalili A, David OJ, Emotte C, Antunes AM, Rose K, Decker J, Carlson I, Gardner H, Stuetz A, Bertolino AP, Stingl G, De Rie MA. Skvara H, et al. Among authors: stingl g. J Invest Dermatol. 2011 Aug;131(8):1735-44. doi: 10.1038/jid.2011.48. Epub 2011 Mar 24. J Invest Dermatol. 2011. PMID: 21430703 Free article. Clinical Trial.
The PKC inhibitor AEB071 may be a therapeutic option for psoriasis.
Skvara H, Dawid M, Kleyn E, Wolff B, Meingassner JG, Knight H, Dumortier T, Kopp T, Fallahi N, Stary G, Burkhart C, Grenet O, Wagner J, Hijazi Y, Morris RE, McGeown C, Rordorf C, Griffiths CE, Stingl G, Jung T. Skvara H, et al. Among authors: stingl g. J Clin Invest. 2008 Sep;118(9):3151-9. doi: 10.1172/JCI35636. J Clin Invest. 2008. PMID: 18688284 Free PMC article. Clinical Trial.
Immunosuppressive therapy in dermatology and PML.
Sterry W, Bagot M, Ferrandiz C, Kragballe K, Papp K, Stingl G. Sterry W, et al. Among authors: stingl g. J Dtsch Dermatol Ges. 2009 Jan;7(1):5. doi: 10.1111/j.1610-0387.2008.06993.x. J Dtsch Dermatol Ges. 2009. PMID: 19138293 Free PMC article. No abstract available.
A rare bullous variant of dermatitis herpetiformis.
Griss J, Stingl G, Schmidt E, Bangert C. Griss J, et al. Among authors: stingl g. Br J Dermatol. 2016 Jan;174(1):231-3. doi: 10.1111/bjd.13941. Epub 2015 Oct 26. Br J Dermatol. 2016. PMID: 26042658 No abstract available.
Efalizumab in routine use: a clinical experience.
Selenko-Gebauer N, Karlhofer F, Stingl G. Selenko-Gebauer N, et al. Among authors: stingl g. Br J Dermatol. 2007 Apr;156 Suppl 2:1-6. doi: 10.1111/j.1365-2133.2007.07762.x. Br J Dermatol. 2007. PMID: 17371316
412 results